Genprex Statistics
Total Valuation
Genprex has a market cap or net worth of $9.76 million. The enterprise value is $8.42 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Genprex has 33.47 million shares outstanding. The number of shares has increased by 721.21% in one year.
| Current Share Class | 33.47M |
| Shares Outstanding | 33.47M |
| Shares Change (YoY) | +721.21% |
| Shares Change (QoQ) | +80.76% |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | 5.94% |
| Float | 33.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.95 |
| P/TBV Ratio | 7.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -612.30% and return on invested capital (ROIC) is -377.18%.
| Return on Equity (ROE) | -612.30% |
| Return on Assets (ROA) | -207.41% |
| Return on Invested Capital (ROIC) | -377.18% |
| Return on Capital Employed (ROCE) | -1,244.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.17M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.22% in the last 52 weeks. The beta is -0.64, so Genprex's price volatility has been lower than the market average.
| Beta (5Y) | -0.64 |
| 52-Week Price Change | -39.22% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.43 |
| Relative Strength Index (RSI) | 68.10 |
| Average Volume (20 Days) | 24,311,541 |
Short Selling Information
The latest short interest is 2.76 million, so 8.25% of the outstanding shares have been sold short.
| Short Interest | 2.76M |
| Short Previous Month | 1.93M |
| Short % of Shares Out | 8.25% |
| Short % of Float | 8.28% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.31M |
| Pretax Income | -27.63M |
| Net Income | -17.56M |
| EBITDA | -17.31M |
| EBIT | -17.31M |
| Earnings Per Share (EPS) | -$1.27 |
Full Income StatementBalance Sheet
The company has $1.35 million in cash and n/a in debt, giving a net cash position of $1.35 million or $0.04 per share.
| Cash & Cash Equivalents | 1.35M |
| Total Debt | n/a |
| Net Cash | 1.35M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 1.39M |
| Book Value Per Share | 0.04 |
| Working Capital | -380,145 |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.31M |
| Capital Expenditures | n/a |
| Free Cash Flow | -13.31M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
